[Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].

Ai, H; Yin, Q S; Wang, Q; Fu, Y W; Wei, X D; Song, Y P

Ai, H; Yin, Q S; Wang, Q; Fu, Y W; Wei, X D; Song, Y P.

Afiliação

Ai H; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Yin QS; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wang Q; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Fu YW; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wei XD; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Song YP; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.

Zhonghua Xue Ye Xue Za Zhi ; 41(3): 239-244, 2020 Mar 14.

Article em Zh | MEDLINE | ID: mdl-32311895

Assuntos

Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Leucemia-Linfoma Linfoblástico de Células Precursoras B/terapia; Adolescente; Adulto; Antígenos CD19; Criança; Feminino; Humanos; Masculino; Estudos Retrospectivos; Linfócitos T; Condicionamento Pré-Transplante; Adulto Jovem

Palavras-chave

Allogeneic hematopoietic stem cell transplantation; B cell leukemia; CAR-T cell; Refractory/relapsed

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: Zh Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google